med question

Combination of antimalarial medication and antibiotics could shorten COVID-19, researchers say

In the midst of the COVID-19 outbreak, researchers are finding a potential way of weakening the novel virus. Check out the new study that is bringing hope to many.

Researchers in France have issued a statement detailing how a combination of antimalarial medication and antibiotics could be a vital weapon in the battle against coronavirus.

The researchers’ work has garnered global attention, notably from President Trump. Researchers prescribed the antimalarial hydroxychloroquine and the antibiotic azithromycin to patients earlier this month, according to the research, which is published in the International Journal of Antimicrobial Agents.

In the statement, which was released Sunday, IHU-Méditerranée Infection in Marseille described the treatment protocol for COVID-19 patients. “A treatment with the hydroxychloroquine combination (200 mg x 3 per day for 10 days) + Azithromycin (500 mg on the 1st day then 250 mg per day for 5 more days), as part of the precautions for use of this association (including an electrocardiogram on D0 and D2)," they write, in the translated statement. “In cases of severe pneumonia, a broad-spectrum antibiotic is also used.”

CORONAVIRUS: COMBINATION OF ANTIMALARIAL MEDICATION AND ANTIBIOTICS COULD SHORTEN COVID-19, RESEARCHERS SAY

“We believe that it is not ethical that this association should not be systematically included in therapeutic trials concerning the treatment of COVID-19 infection in France,” the researchers add.

IHU Méditerranée Infection@IHU_Marseille

· 10h

Communiqué de l'IHU Méditerranée Infection du 22/03/2020https://www.mediterranee-infection.com/epidemie-a-coronavirus-covid-19/ …

IHU Méditerranée Infection@IHU_Marseille